Opportunity ID: 356687

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-25-123
Funding Opportunity Title: Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 10, 2024
Last Updated Date: Oct 10, 2024
Original Closing Date for Applications: May 07, 2025
Current Closing Date for Applications: May 07, 2025
Archive Date: Jun 12, 2025
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Native American tribal governments (Federally recognized)
Independent school districts
Private institutions of higher education
For profit organizations other than small businesses
Special district governments
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PA-25-123.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 356687 Full Announcement-PA-25-123 -> PA-25-123-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-I Use for due dates on or after January 25, 2025 PKG00288406 Jan 16, 2025 May 07, 2025 View

Package 1

Mandatory forms

356687 RR_SF424_5_0-5.0.pdf

356687 PHS398_CoverPageSupplement_5_0-5.0.pdf

356687 RR_OtherProjectInfo_1_4-1.4.pdf

356687 PerformanceSite_4_0-4.0.pdf

356687 RR_KeyPersonExpanded_4_0-4.0.pdf

356687 PHS398_ResearchPlan_5_0-5.0.pdf

356687 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

356687 RR_Budget_3_0-3.0.pdf

356687 RR_SubawardBudget30_3_0-3.0.pdf

356687 PHS398_ModularBudget_1_2-1.2.pdf

356687 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T09:59:03-05:00

Share This Post, Choose Your Platform!

About the Author: